ArticleCancer communications (London, England)2022

Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target.

Yingkuan Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.